CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers

CDCP1, a transmembrane noncatalytic receptor, the expression of which has been associated with a poor prognosis in certain epithelial cancers, was found to be expressed in highly aggressive triple-negative breast cancer (TNBC) cell models, in which it promoted aggressive activities—ie, migration, in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Turdo, Federica, Bianchi, Francesca, Gasparini, Patrizia, Sandri, Marco, Sasso, Marianna, De Cecco, Loris, Forte, Luca, Casalini, Patrizia, Aiello, Piera, Sfondrini, Lucia, Agresti, Roberto, Carcangiu, Maria Luisa, Plantamura, Ilaria, Sozzi, Gabriella, Tagliabue, Elda, Campiglio, Manuela
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342505/
https://ncbi.nlm.nih.gov/pubmed/27626701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11935
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares